Big-cap biotech and IBD 50 stock Gilead Sciences put an important brick in its fortress against competition Wednesday when it reported positive trial data for its latest HIV drug. Its stock rose 3% to 108.66 on the news. The drug, called tenofovir alafenamide (TAF), has been nicknamed “Son of Viread” by Wall Street because it’s a new and improved version of Gilead’s (GILD) flagship HIV drug Viread. Since Viread first hit the market in 2001, most
Will the Internet TV ambitions of Dish Network and Verizon Communications dovetail into a merger or network-sharing deal between them? That scenario looms, some analysts say, as both the satellite TV broadcaster and the nation’s No. 1 wireless phone company ready Web and mobile TV services. Dish Network (DISH) is expected to launch an Internet TV service — also called over-the-top or OTT service — by year’s end. Dish on Sept. 16 added Scripps
Nielsen, the company that measures TV viewership, holds a key part of the puzzle as Verizon Communications aims to whisk live and on-demand shows to users of mobile devices. Nielsen (NLSN), which for decades has tracked what couch potatoes watch in living rooms, has said that by the fourth quarter it plans to have a system to measure how much video consumers watch on mobile devices. Verizon Wireless (VZ), meanwhile, is in talks with media and